Results 61 to 70 of about 42,543 (244)
Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
Background This study assessed the Granzyme B (GrB) ELISPOT as a viable alternative to the 51Cr-release assay for measuring cytotoxic activity of innate immune effector cells.
Baseler Michael +6 more
doaj +1 more source
Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
This study showed that a mAb (145-2C11) against the T3 epsilon-chain of the TCR complex augmented the cytotoxic activity of the lymphokine-activated killer (LAK) effectors.
C. Ting, M. Hargrove, Y. Yun
semanticscholar +1 more source
Current status of endoscopic ultrasound‐guided antitumor treatment for pancreatic cancer
Endoscopic ultrasound (EUS) was developed in the 1990s and has significantly transformed pancreatic tumor diagnosis. Subsequently, EUS has rapidly shifted from being a purely diagnostic procedure to being used in a wide range of interventional procedures.
Kazuyuki Matsumoto +3 more
wiley +1 more source
Natural killer and lymphokine activated killer cell functions in Hodgkin's disease [PDF]
We report the natural killer (NK) and lymphokine activated killer (LAK) cell activities in peripheral blood lymphocytes (PBL) from untreated patients with Hodgkin's disease (HD) and from healthy donors. The frequency of LAK cell precursors was also studied using limiting dilution analysis (LDA).
N, Rajaram +3 more
openaire +2 more sources
Coronary artery disease (CAD) is a complex condition influenced by genetic factors, lifestyle, and other risk factors that contribute to increased mortality. This study is aimed at evaluating the diagnostic potential of genes associated with cuproptosis, ferroptosis, and pyroptosis (CFP) using network modularization and machine learning methods.
Yongyi Zhang +11 more
wiley +1 more source
Specific immunotherapy in renal cancer: a systematic review
Background: Renal cell cancer (RCC) is the tenth most common malignancy in adults. In recent years, several approaches of active and passive immunotherapy have been studied extensively in clinical trials of patients with RCC.
Armin Hirbod-Mobarakeh +6 more
doaj +1 more source
TIL Therapy in Lung Cancer: Current Progress and Perspectives
Unveiling the promise of Tumor‐Infiltrating Lymphocytes (TIL) therapy for lung cancer treatment. This review introduces why TIL therapy is suitable for lung cancer, delves into its historical and clinical developments, and discusses methods for identifying tumor‐recognizing TILs and optimizing TIL composition.
Weilei Hu, Yifei Bian, Hongbin Ji
wiley +1 more source
COX‐2 in lung cancer: Mechanisms, development, and targeted therapies
COX‐2 functions in the tumor microenvironment. Abstract Lung cancer (LC) is the leading cause of cancer‐related death worldwide, with non‐small cell lung cancer (NSCLC) comprising 85% of all cases. COX‐2, an enzyme induced significantly under stress conditions, catalyzes the conversion of free arachidonic acid into prostaglandins.
Xueqi Liu +4 more
wiley +1 more source
We previously demonstrated that IL-2 promotes the adhesion of NK cells to endothelial cells (EC) and that EC are readily lysed by lymphokine-activated killer (LAK) cells in vitro, suggesting that cell mediated endothelial injury may contribute to the ...
James W. Mier +4 more
semanticscholar +1 more source
Mycobacterium tuberculosis acts as the causative agent of human tuberculosis and is regarded as one of the most adaptable human pathogens. M. tuberculosis possesses several virulence factors that help the bacterium evade mucous barriers. The infection caused by M.
Noura Mohammadnabi +8 more
wiley +1 more source

